National Māori Pandemic Group wins recognition for Covid-19 response
A pandemic health initiative won the top award at a celebration of Māori excellence.
Vast majority of Australians want COVID-19 boosters
More than seven-in-10 vaccinated Australians say they will definitely get a COVID-19 vaccine booster shot when it is recommended to them...
University of glasgow launches new course to support children and young people in the...
A new free online course launching today (Monday 20 June 2022) will look at how young people’s emotional wellbeing has been impacted by the COVID-19 crisis.
How Canadians’ lifestyle behaviours changed during the COVID-19 pandemic
Sixty per cent of roughly 1,600 Canadians who took part in a new McGill University study say their lifestyle habits either stayed the same or improved during the COVID-19 pandemic.
University of Bristol students launch international charity scheme
A scheme set up by five University of Bristol undergraduates has begun to support charities across the globe during the COVID-19 pandemic.
McMaster researchers receive SSHRC funding to study economic and labour impacts of COVID-19 pandemic
Three McMaster researchers have received nearly $75,000 combined from the Social Sciences and Humanities Research Council (SSHRC).
University study finds economic window for native grains production
At the start of NAIDOC Week 2020, Dr Angela Pattison and colleagues have launched the first report from a feasibility study into using native grass grains as a modern...
How the Sydney cluster grew—and what it could mean for New Zealand
With news of a new strain of the Covid-19 virus spreading in the UK, it looks like Australia’s Christmas plans are also up in the air with a new cluster of cases in Sydney.
Building equity into vaccine distribution
Who gets priority? If the pandemic is hitting certain communities harder, can they be adequately supplied with vaccine doses?
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.
- Advertisement -
